CTRI/2017/06/008942尚未招募4 期
Evaluation of Ulipristal in medical management of symptomatic uterine leiomyoma -
College of Medicine and JNM Hospital0 个研究点目标入组 50 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. 18 to 50 years of age group
- •2. A score on the pictorial blood-loss assessment chart (PBAC, in which monthly scores range from 0 to >500, with higher numbers indicating more bleeding) higher than 100 during days 1 to 8 of menstruation.
- •3. Fibroid-related anemia, defined as a hemoglobin level of 10.0 g per deciliter or lower.
- •4. Uterine size equivalent to that of a uterus at 16 weeks or less of gestation.
- •5. Atleast one fibroid that was 3 cm or more in diameter
排除标准
- •1. Leiomyoma more than 10 cm
- •2. Associated with Pregnancy.
- •3. Who do not agree for consent.
- •4. Contraindication or known allergy to ulipristal
研究者
相似试验
进行中（未招募）
不适用
ulipristal acetate in the management of fibroid uterusCTRI/2020/03/024325sangam jha
尚未招募
不适用
To Compare the Efficacy Of Tablet Ulipristal Acetate with inj GnRH agonist in Women with Fibroid UterusCTRI/2016/10/007336ot Applicable64
进行中（未招募）
2 期
TO evaluate the safety and efficacy of Unani medicines (Funduq and Shaqaqul) in the management of Male Infertility.CTRI/2017/08/009389Govt Nizamia Tibbi College30
进行中（未招募）
2 期
Assess the Baboola fruit powder pharmaco-clinically for its Calcium contents with different anupana.CTRI/2019/04/018535Parul Iinstitute of Ayurved
已完成
2 期
Effect of Uraimathirai in Increasing children ImmunityCTRI/2017/06/008723CENTRAL COUNCIL FOR RESEARCH IN SIDDHA